BactiVax (anti-Bacterial Innovative Vaccines) is an innovative European Training Network that will provide high-level training in vaccinology to 15 Early Stage Researchers (ESRs), and equip them with a wide range of transferable skills for thriving careers in vaccine research within academia and industry. BactiVax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening infections. This network comprises 14 Principal Investigators from 8 European countries and two companies which will collectively train ESRs.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 860325.
This page reflects only the authors’ view and the Research Executive Agency is not responsible for any use that may be made of the information it contains.
Company Details
- Founded
- -
- Address
- Dublin, Dublin D4, Ie
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.bactivax.eu/
- Keywords
- Vaccine Research, Biochemistry, Vaccinology, Proteomics, Medicine, Microbiology, Immunology, Structural Biology, Glycochemistry, Peptide Chemistry, Medicinal Chemistry, Training, Research Dissemination, Outreach.
- HQ
- Dublin, Dublin
Bactivax Itn Questions
Bactivax Itn's website is https://www.bactivax.eu/
Bactivax Itn's LinkedIn profile is https://ie.linkedin.com/company/bactivax-itn
Bactivax Itn's industry is
Research Services
Bactivax Itn's top competitors are
Biocina,
Ucc Biology Society,
Bio-Angle Vacs,
Hafion, Inc.,
Gylden Pharma,
Althost Consortium,
Precivax Therapeutics,
Gennova Biopharmaceuticals,
Scotia Biologics,
Bactivac.
Bactivax Itn's categories are Research Services
Bactivax Itn's founding year is 2019
